UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Identify a reliable starting point by focusing on liquidity, security, and real-world use cases that resonate with new investors.
23,507 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Walmart recently released its latest quarterly results, but the stock moved on macro concerns as much as fundamentals...
A top analyst’s optimistic view on Micron highlights AI-driven memory demand and a potential upcycle in DRAM and NAND...
Regulators pause the Union Pacific Norfolk Southern megamerger review, injecting regulatory risk for Norfolk Southern...
A sharp May rally pushed Planet Labs stock higher on renewed growth expectations and a favorable data-demand backdrop...
Costco reports a strong surge in online demand alongside record gas volume, but the stock still slid. This analysis e...
When the tech market cools, patient investors can find real opportunities. This guide highlights two blue‑chip names ...
SpaceX hit the public markets with an IPO price of $135 per share, signaling a game-changing moment for growth invest...
Nvidia sits at the center of AI-driven growth. This guide examines potential price paths for what will nvidia stock's...
This satellite data stock has pulled back after a scorching rally. In this guide, you’ll learn what powers its busine...
June brought a momentum burst in niche tech, led by space-based connectivity. This article breaks down the stock mark...
A rare forecast from wall street analysts predicting a paradox: rising prices paired with weakening fundamentals. Thi...